Effect and predictive elements for 52 weeks' telbivudine treatment on naïve HBeAg positive chronic hepatitis B

Hepatitis Monthly

Volumn 11, Issue 12, 2011, Pages 980-985

  Zhu, Xiao Feng ^a   Lu, Li Xia ^a,b   Wang, Ying ^a,b   Xu, Kong Wen ^a,b   Li, Da Jiang ^b   Zhu, Xia ^a,b   Liu, Li ^a,b   Liu, Cong ^a,b   Wang, Jin Rong ^a,b   Tang, Hong ^a,b   Wang, Li Chun ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Alanine; Chronic; Hepatitis B; Hepatitis B virus; Predictive value of tests; Telbivudine; Transaminase

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; TELBIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; FEMALE; GENE DOSAGE; HEPATITIS B; HUMAN; INSOMNIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUSCLE WEAKNESS; MYALGIA; PANCREATITIS; PREDICTION; SEROCONVERSION; SEROLOGY; SIDE EFFECT; TREATMENT DURATION;

EID: 84862915577     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.4203     Document Type: Article

References (19)

1. Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline on prevention and treatment of chronic hepati- tis B in China (2005). Chin Med J (Engl). 2007;120(24):2159-73.
2. McKeage K, Keam SJ. Telbivudine: a review of its use in compensated chronic hepatitis B. Drugs. 2010;70(14):1857-83.
3. Hynicka LM, Yunker N, patel PH. A review of oral antiretroviral therapy for the treatment of chronic hepatitis B. Ann Pharmaco- ther. 2010;44(7-8):1271-86.
4. Keeffe EB, Zeuzem S, Koff RS, Dieterich DT, esteban-Mur R, Gane EJ, et al. Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol. 2007;5(8):890-7.
5. Duong A, Mousa SA. Current status of nucleoside antivirals in chronic hepatitis B. Drugs Today (Barc). 2009;45(10):751-61.
6. Lau GK. Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion. Liver Int. 2010;30(4):512-20.
7. Almeida AM, Ribeiro AQ, padua CA, Brandao CM, Andrade EI, Cherchiglia ML, et al. The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a system- atic review. Rev Soc Bras Med Trop. 2010;43(4):440-51.
8. Osborn MK. Safety and efficacy of telbivudine for the treatment of chronic hepatitis B. Ther Clin Risk Manag. 2009;5:789-98.
9. Yuen MF, Lai CL. Telbivudine for chronic hepatitis B: the GLoBe trial. Future Virol. 2008;3(4):317-23.
10. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582-92.
11. Liaw YF, Lau GK, Kao JH, Gane E. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig Dis Sci. 2010;55(10):2727-34.
12. Lv GC, Ma WJ, Ying LJ, Jin X, Zheng L, Yang YD. Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels. World J Gastroenterol. 2010;16(32):4095-9.
13. Hann HW. Telbivudine: an effective anti-HBV drug for chronic hepatitis B patients with early on-treatment responses. Expert Opin Pharmacother. 2010;11(13):2243-9.
14. Brunetto MR, Lok AS. New approaches to optimize treatment responses in chronic hepatitis B. Antivir Ther. 2010;15(Suppl 3):61-8.
15. Kahloun A, Bourliere M, Zoulim F. Analogs combination therapy in chronic hepatitis B: when and how?. Gastroenterol Clin Biol. 2010;34(Suppl 2):S126-35.
16. Gane EJ. The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B. Hepatol Int. 2008;2(3):304-7.
17. Seto WK, Lai CL, Fung J, Wong DK, Yuen JC, Hung IF, et al. Significance of HBV DnA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome. J Hepatol. 2011;55(3):522-8.
18. Yogeswaran K, Fung SK. Chronic hepatitis B in pregnancy: unique challenges and opportunities. Korean J Hepatol. 2011;17(1):1-8.
19. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009;49(5 Suppl):S185-95.